Brind.

Abbott Japan and Agilent Technologies were identified as key players in the biochip market as of July 18, 2025.

1 report, 1 independent Updated Jul 18

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Abbott Japan Agilent Technologies

Keep exploring

The entities involved

Abbott Japan
Nothing else this week.
Agilent Technologies
American life sciences company that provides instruments, software, services, and consumables for the entire laboratory workflow
- Keysight Technologies was spun off from Hewlett-Packard on August 20, 2025.Sun 05:01
- Jerome Powell's comments regarding monetary policy were discussed on August 29, 2025, in the context of thematic investing and their impact on companies like Agilent Technologies and Microsoft.Sun 02:58

Coverage

Newest first; wire copies grouped

Jul 18GlobeNewswireBiochip Market Global Outlook Report 2025, with Focus on Microarrays and Lab-on-a-Chip Discover comprehensive insights into the global biochip market, providing revenue analysis, trends, and forecast